Investing in food, agricultural infrastructure should be national priority: Agri varsity VC
He was speaking at the CII Karnataka Food Processing & Agri Conclave 2025.
The conclave brought together industry leaders, policymakers, and experts to discuss the future of the state's agriculture and food processing sectors.
"A call to action is needed to reduce food waste, enhance value addition, and build a more resilient food supply chain," Suresha said while speaking at CII Karnataka Agri & Food Processing Panel.
According to him, the next two years are crucial for strategic interventions.
"India currently loses one-third of its food grains due to inadequate processing, with only two-thirds being integrated into formal channels," he added.
He said the university is holding outreach programmes and collaborations to empower farmers and advance agricultural technology.
Karnataka Watershed Department Director M H Banthanal discussed the crucial role of integrated watershed development in fostering sustainable agriculture and empowering rural communities across Karnataka.
"The department is leveraging technology like remote sensing and GIS to monitor outcomes, and has successful case studies that have resulted in improved groundwater levels and increased agricultural incomes," he added.
Tanay Joshi, Director, Agriculture and Livelihoods Social Sector, at Ernst & Young LLP, said India stands at a pivotal moment in the global food processing landscape.
"Despite being the second-largest producer of food grains, fruits, and vegetables, India processes 10 per cent of its agricultural yield," he said.
According to him, supportive government policies, a young population, and digital growth are key drivers.
Rabindra Srikantan, Chairman, CII Karnataka State Council shared details on CII's FACE .
He said FACE has been doing commendable work nationally by promoting food safety, traceability, agri-tech adoption, and building capacity across the value chain.
ASM Technologies Ltd managing director Srikantan said, "We are also working closely with various departments to bring FACE's resources and frameworks to Karnataka in a more direct and impactful way."
The panel was attended by over 100 participants from across the industry.
This article was generated from an automated news agency feed without modifications to text.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Agniveer recruitment rally from today In Raichur
Raichur: The Agniveer recruitment rally is set to take place here from Aug 8 to 26, aimed at motivating the youth of Kalyana Karnataka to enlist in the Indian Army in significant numbers. The district administration has undertaken comprehensive preparations for the recruitment rally, which is scheduled to take place at the University of Agricultural Sciences. According to Krishna Shawantgera, deputy director of the food department, the district administration will provide free accommodation, food, water, and transportation services to 2,000 people daily throughout the 19-day rally. Donations are being received from various associations and organisations to support these efforts. Candidates arriving for recruitment will be accommodated in several hostels in the city, including Valmiki Bhavan, Banjar Bhavan, and Santoshi Hub. Transportation facilities have been arranged for candidates from the bus stand to the hostels, available at a cost of just Rs 10. It is estimated that approximately 80,000 candidates will participate in the 19-day rally, supported by a budget of Rs 30 lakh to provide necessary facilities. Local traders have committed to supplying rice, vegetables, drinking water, cooking, serving food, and overseeing the arrangements, said Chandrashekhar Mirjapur, an office bearer of the Ishwari Temple Committee. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and s ilver prices in your area.
Time of India
2 hours ago
- Time of India
Biocon Q1 net profit falls 95% to Rs 31 crore
Representative image NEW DELHI: Biocon on Thursday reported a 95 per cent decrease in its consolidated net profit at Rs 31 crore in the June quarter. The Bengaluru-based firm posted a net profit of Rs 660 crore in the April-June quarter of the last fiscal. Total revenue declined to Rs 4,022 crore in the June quarter as against Rs 4,567 crore in the year-ago period, Biocon Ltd said in a statement. "Biocon opened FY26 with a strong performance, driven by continued gains in Biosimilars and CRDMO, and a steady showing in Generics," Kiran Mazumdar-Shaw, Chairperson, Biocon Group, stated. Operating revenue rose 15 per cent YoY to Rs 3,942 crore, with EBITDA up 19 per cent on a like-for-like basis, demonstrating operating leverage and the robustness of businesses, she added. "The recent QIP has strengthened our balance sheet and enabled us to increase our ownership in Biocon Biologics by facilitating the exit of structured equity investors, aligning capital structure with long-term strategic priorities," Mazumdar-Shaw said. With execution momentum across all businesses and expanded capacity through acquisitions in the US by Syngene and Biocon Generics, the company is well-positioned to drive long-term value creation in FY26 and beyond, she added. Stay informed with the latest business news, updates on bank holidays and public holidays .
Mint
2 hours ago
- Mint
Biocon revenue grows 15%, profit dips sharply
Biocon posted its financial results for the quarter ending 30 June with its revenue from operations up 15% year-on-year at ₹3,942 crore, driven by gains in its biosimilars and CRDMO businesses. Its net profit fell 95% compared to the same quarter in the previous year due to a one-time gain from the divestment of its branded formulations business in Q1FY25. Biocon's net profit for the quarter was at ₹31 crore, compared to ₹660 crore in Q1FY25. Excluding the divestment gain from Q1FY25, its profit increased by 65%, the company said in a release. The Bengaluru-based drugmaker's revenue and profit missed street estimates. A Bloomberg poll of 11 brokerages had pegged its revenue at ₹4,024 crore and profit after tax at ₹111.7 crore. The company reported an Ebitda of ₹829 crore, down 53% year-on-year. Excluding the divestment gain, its Ebitda was up 19%, the company said. Ebitda margins contracted to 21% from 38% in the same period last year. The company's biosimilars business, which accounts for 61% of its overall revenue, posted revenue of ₹2,458 crore, up 18% year-on-year. The generics business posted a revenue of ₹697 crore, up 6% YoY, and the CRDMO business, under Syngene International, posted a growth of 11% to ₹875 crore. Also Read | India restricts sale of TB drugs to government channels to curb resistance 'Biocon opened FY26 with a strong performance, driven by continued gains in biosimilars and CRDMO, and a steady showing in generics. Operating revenue rose 15% YoY to ₹3,942 crore, with Ebitda up 19% on a like-for-like basis, demonstrating operating leverage and the robustness of our businesses,' Kiran Mazumdar-Shaw, chairperson, Biocon Group, said in a statement. Successful QIP raise During the quarter, the company raised ₹4,500 crore through a qualified institutional placement (QIP). The funds will be used to increase Biocon's holding in its subsidiary Biocon Biologics, and provide an exit to private equity investors, the company said in the release. 'The recent QIP has strengthened our balance sheet and enables us to increase our ownership in Biocon Biologics by facilitating the exit of structured equity investors, aligning capital structure with long-term strategic priorities,' Shaw said. Biocon had said in the last quarter that its board had set up a committee to evaluate a merger of Biocon Biologics with the parent firm. During the quarter, the company launched its tenth global biosimilar, Yesafili, which is used to treat ophthalmology conditions in Canada, and received USFDA approval for Insulin Aspart.
